IDO1 and malignant colon neoplasm: To determine the contribution of the Kyn pathway to NAD+ levels, we measured NAD(H) in HCT15 and DLD1 colon cancer cells treated with the inhibitors of TDO2 and IDO for 24 h (Supplemental Fig. S9A–C).